Metraipolis › archive › dc_010171453534
Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer — Europe PMC PMID:42092972
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42092972
- DOI
- 10.1186/s12931-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T17:08:26.924Z
- SHA-256 of the archived text
defe4ddc26a8fb35dceef979f758bc689e60c49fa47b106b693cd17a1d136aec- Stable URL of this page
https://metraipolis.com/documento/dc_010171453534
How to cite
Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer — Europe PMC PMID:42092972 — Europe PMC (en), https://europepmc.org/article/MED/42092972 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_010171453534 (Metraipolis archive dc_010171453534, sha256 defe4ddc26a8fb35dceef979f758bc689e60c49fa47b106b693cd17a1d136aec)
BibTeX
@misc{dc010171453534,
title = {Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer — Europe PMC PMID:42092972},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42092972},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_010171453534; sha256 defe4ddc26a8fb35dceef979f758bc689e60c49fa47b106b693cd17a1d136aec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42092972. Agents can read the archived copy with the MCP tool read_document.